Viewing Study NCT01275859


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2025-12-26 @ 2:15 AM
Study NCT ID: NCT01275859
Status: COMPLETED
Last Update Posted: 2017-08-29
First Post: 2011-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module